Topics

breakthrough cases

"... an instance in which a person becomes sick with a disease despite having received the vaccine for that disease. In other words, the vaccine fails to prevent the person from becoming infected."

Source:  https://www.dictionary.com/e/tech-science/breakthrough-case/

‘Bombshell’ CDC Study: Kids Who Got Pfizer Vaccine More Likely Than Unvaccinated to Get COVID Infection
552 Fully Vaccinated Oregon Residents Died Of COVID-19, Half Received Pfizer Vaccine
Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model
All Cause Mortality and COVID-19 Injections: Evidence from 28 Weeks of Public Health England “COVID-19 Vaccine Surveillance Reports”
An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam
An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021
Appendix 1: estimation of number needed to vaccinate to prevent a COVID-19 hospitalisation for primary vaccination, booster vaccination (3rd dose), autumn 2022 and spring 2023 booster for those newly in a risk group
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance
Causal effect of covid vaccination on mortality in Europe
Citizen Petition for the Issuance of a Rule Regarding Freedoms for the Convalesced following COVID-19 Disease
Commentary: Shockingly, CDC Now Lists Vaccinated Deaths as Unvaccinated
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
Compilation of Donald Trump promoting COVID-19 vaccines
Correlation of SARS-CoV-2 breakthrough infections to time-from-vaccine
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May – November 2021
COVID-19 cases with Lineage B.1.1.529 (Omicron) or S-Gene Target Failure (SGTF) in Ontario: October 31, 2021 to December 29, 2021
COVID-19 in Northern Ireland: Vaccination Status of Deaths and Hospitalisations — Updated to Include Weeks 51 to 2 (20th December 2021 to 16th January 2022)
Covid-19 in Wales: A third of positive cases are unvaccinated
COVID-19 Infection Rates in Vaccinated and Unvaccinated Inmates: A Retrospective Cohort Study
COVID-19 Monitor: COVID-19 cases, variants, vaccines, hospitalisations and deaths
Covid-19 Rapport om omikronvarianten
COVID-19 Risk Monitoring Dashboard – Healthcare settings
COVID-19 vaccinations data
COVID-19 Vaccine Breakthrough Case Investigation and Reporting
COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021
COVID-19 vaccine safety update: Primary series in young children and booster doses in older children and adults
COVID-19 vaccine surveillance report, Week 13
COVID-19 vaccine surveillance report, Week 2
COVID-19 vaccine surveillance report, Week 42
COVID-19 vaccine surveillance report, Week 43
COVID-19 vaccine surveillance report, Week 44
COVID-19 vaccine surveillance report, Week 48
COVID-19 vaccine surveillance report, Week 5 2022
COVID-19 Weekly Surveillance in NSW: Epidemiological Week 52 ending 1 January 2022
Covid-19: Fully vaccinated people can carry as much delta virus as unvaccinated people, data indicate
Dataset: Deaths occurring between 1 January 2021 and 31 May 2022 edition of this dataset
Dispelling the Myth of a Pandemic of the Unvaccinated
Dr David Bauer: ‘Pfizer vaccine produces fewer key antibodies’ – MSN News
Dr. Peter McCullough presentation at 78th Annual Meeting of Association of American Physicians and Surgeons (AAPS)
Dr. Scot Youngblood presentation to the San Diego City Council
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022
Effectiveness of COVID-19 vaccines against Omicron or Delta infection
Effectiveness of mRNA COVID-19 Vaccines Against the Delta Variant Among 5.6M Medicare Beneficiaries 65 Years and Older
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Effectiveness of the 2023-2024 Formulation of the Coronavirus Disease 2019 mRNA Vaccine against the JN.1 Variant
Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant
Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine
764